PMID- 31474455 OWN - NLM STAT- MEDLINE DCOM- 20210927 LR - 20210927 IS - 1477-2574 (Electronic) IS - 1365-182X (Linking) VI - 22 IP - 4 DP - 2020 Apr TI - Embolization with microspheres alone for hepatocellular carcinoma with portal vein tumor: analysis of outcome and liver function at disease progression. PG - 588-594 LID - S1365-182X(19)30689-6 [pii] LID - 10.1016/j.hpb.2019.08.004 [doi] AB - BACKGROUND: This retrospective study reviews long-term outcome of hepatic artery embolization (HAE) using microspheres alone in patients presenting with Hepatocellular Carcinoma (HCC) and portal vein tumor (PVT). METHODS: From 2005 to 2015, 43 patients with HCC and PVT underwent HAE. Response to treatment, time-to-progression (TTP), local-tumor-progression (LTP), distant-hepatic-progression (DHP), PVT-progression (PVTP), and/or the development of extra-hepatic progression (EHP) were assessed on pre-HAE CT/MRI scans, within 4 weeks post-HAE and at quarterly intervals thereafter, along with liver function (Child-Pugh score, CP). RESULTS: Forty (40/43) patients progressed during a median follow-up of 10 months with a median TTP of 2.9 months. Eleven of the 40 patients (27.5%) developed EHP, with only 2 patients (5%) demonstrating solely LTP. Six patients (15%) developed PVTP only. At progression, 27 patients (27/40, 77%) maintained their initial CP status, including all 5 CP-B patients. Median survival was 12.5 (95% CI 8-23) months for the entire group; 17.3 (95% CI 10-33) months for the patients with segmental/lobar PVT, compared with 8.4 (95% CI 6-13) months for the patients with main PVT (p = 0.02). CONCLUSION: HAE can be used to treat patients with HCC and PVT with median survival of approximately a year and preserved liver function. CI - Copyright (c) 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved. FAU - Borgheresi, Alessandra AU - Borgheresi A AD - Department of Radiology, 1275 York Avenue, New York, NY, 10065, USA. FAU - Covey, Anne AU - Covey A AD - Department of Radiology, 1275 York Avenue, New York, NY, 10065, USA; Weil Cornell Medical College, 1300 York Avenue, New York, NY, 10065, USA. FAU - Yarmohammadi, Hooman AU - Yarmohammadi H AD - Department of Radiology, 1275 York Avenue, New York, NY, 10065, USA; Weil Cornell Medical College, 1300 York Avenue, New York, NY, 10065, USA. FAU - Boas, Franz E AU - Boas FE AD - Department of Radiology, 1275 York Avenue, New York, NY, 10065, USA; Weil Cornell Medical College, 1300 York Avenue, New York, NY, 10065, USA. FAU - Ziv, Etay AU - Ziv E AD - Department of Radiology, 1275 York Avenue, New York, NY, 10065, USA; Weil Cornell Medical College, 1300 York Avenue, New York, NY, 10065, USA. FAU - Getrajdman, George AU - Getrajdman G AD - Department of Radiology, 1275 York Avenue, New York, NY, 10065, USA; Weil Cornell Medical College, 1300 York Avenue, New York, NY, 10065, USA. FAU - Erinjeri, Joseph AU - Erinjeri J AD - Department of Radiology, 1275 York Avenue, New York, NY, 10065, USA; Weil Cornell Medical College, 1300 York Avenue, New York, NY, 10065, USA. FAU - Jarnagin, William AU - Jarnagin W AD - Department of Surgery, 1275 York Avenue, New York, NY, 10065, USA; Weil Cornell Medical College, 1300 York Avenue, New York, NY, 10065, USA. FAU - Harding, James J AU - Harding JJ AD - Department of Medicine Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA; Weil Cornell Medical College, 1300 York Avenue, New York, NY, 10065, USA. FAU - D'Angelica, Michael AU - D'Angelica M AD - Department of Surgery, 1275 York Avenue, New York, NY, 10065, USA; Weil Cornell Medical College, 1300 York Avenue, New York, NY, 10065, USA. FAU - Gonen, Mithat AU - Gonen M AD - Department of Biostatistics, Memorial Sloan Kettering Cancer Center, 485 Lexington Avenue, New York, NY 10017, USA. FAU - Brown, Karen T AU - Brown KT AD - Department of Radiology, 1275 York Avenue, New York, NY, 10065, USA; Weil Cornell Medical College, 1300 York Avenue, New York, NY, 10065, USA. Electronic address: karen.brown@utah.edu. LA - eng PT - Journal Article DEP - 20190829 PL - England TA - HPB (Oxford) JT - HPB : the official journal of the International Hepato Pancreato Biliary Association JID - 100900921 SB - IM MH - Adult MH - Aged MH - Carcinoma, Hepatocellular/mortality/pathology/*therapy MH - Disease Progression MH - *Embolization, Therapeutic MH - Female MH - Humans MH - Liver Neoplasms/mortality/pathology/*therapy MH - Male MH - *Microspheres MH - Middle Aged MH - *Portal Vein MH - Retrospective Studies MH - Survival Rate MH - Treatment Outcome EDAT- 2019/09/03 06:00 MHDA- 2021/09/28 06:00 CRDT- 2019/09/03 06:00 PHST- 2019/04/16 00:00 [received] PHST- 2019/07/08 00:00 [revised] PHST- 2019/08/07 00:00 [accepted] PHST- 2019/09/03 06:00 [pubmed] PHST- 2021/09/28 06:00 [medline] PHST- 2019/09/03 06:00 [entrez] AID - S1365-182X(19)30689-6 [pii] AID - 10.1016/j.hpb.2019.08.004 [doi] PST - ppublish SO - HPB (Oxford). 2020 Apr;22(4):588-594. doi: 10.1016/j.hpb.2019.08.004. Epub 2019 Aug 29.